Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Boston Convention and Exhibition Center

Jun 23, 2013 8:30 AM - Jun 27, 2013 12:45 PM

415 Summer Street, , Boston, MA 02210 , USA

DIA 2013 49th Annual Meeting: Advancing Therapeutic Innovation and Regulatory Science

Tethering the Channels of Scientific and Medical Content

Session Chair(s)

J. Lynn  Bass, PharmD, RPh

J. Lynn Bass, PharmD, RPh

Senior Director, Medical Science Liaisons

BridgeBio, United States

Scientific communications are integral in channeling the activities within the clinical, medical, regulatory and other functional areas of pharmaceutical companies to ensure the safe and effective utilization of medications. As the internal drivers of scientific and medical content, Medical Science Liaisons, Medical Communications, and Medical Writing functions are being utilized to guide these communication channels and are responsible for the scientific interface with both customers and health care professionals. As companies and our industry evolve, it is imperative for communications from each of these functions be streamlined and coordinated. This session will discuss how each of these functional areas contributes to the overall scientific communications strategy in their unique modes. Best practices for working cross-functionally and an overview of tools for measuring success will be discussed.

Learning Objective : Discuss the unique roles of the medical communications, medical science liaison, and medical writing disciplines; Recognize how cross-functional departmental planning enhances medical communication practices; Identify best practices for successful cross-functional interactions to achieve value added deliverables.

Speaker(s)

Jennifer  Sliwa, PharmD, RPh

Medical and Scientific Content

Jennifer Sliwa, PharmD, RPh

Janssen Scientific Affairs, LLC, United States

Director, Medical Information

David B. Clemow, PhD

Medical Writing Contribution to Medical Communication Designed to Meet Customer Needs

David B. Clemow, PhD

Eli Lilly and Company, United States

Advisor, Scientific Communications Information Strategy

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.